<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04903808</url>
  </required_header>
  <id_info>
    <org_study_id>Lobnamagdy128</org_study_id>
    <nct_id>NCT04903808</nct_id>
  </id_info>
  <brief_title>Clinical And Cost- Effectiveness of Allium Sativum Oil (Garlic Oil ) Versus Mineral Trioxide Aggregate in Primary Molars Pulpotomy in Group of Egyptian Children : A Randomised Clinical Pilot Study.</brief_title>
  <official_title>Clinical And Cost- Effectiveness of Allium Sativum Oil Versus Mineral Trioxide Aggregate in Primary Molars Pulpotomy in Group of Egyptian Children : A Randomised Clinical Pilot Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Allium Sativum oil is advocated to prove the capability of new natural products in replacing&#xD;
      higher cost pharmacological materials, while achieving the same successful clinical and&#xD;
      radiographic long-term results.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the most challenging subjects in paediatric dentistry is choosing the ideal pulp&#xD;
      medication material that has the required properties such as preserving the vitality of the&#xD;
      remaining intact pulp and stimulating its repair. This material should prevent pathological&#xD;
      root resorption.Clinical and cost effectiveness trials from different countries are useful to&#xD;
      determine which medicament should be advocated in which economic setting . Alternative&#xD;
      pulpotomy materials clinically effective as MTA but with lower cost should be studied .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>It is a double-blinded randomised clinical trial with equal randomisation parallel design with allocation ratio 1:1</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>participants and outcome assessor will be blinded (double blind study )</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical effectiveness</measure>
    <time_frame>1 year follow up</time_frame>
    <description>clinical effectiveness will be measured by intraoral examination and radiographic assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>1 year follow up</time_frame>
    <description>cost-effectiveness will be measured with incremental cost-effectiveness ratio (ICER)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">26</enrollment>
  <condition>Carious Primary Molars</condition>
  <arm_group>
    <arm_group_label>Allium sativum oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The pulp stumps of the molars are dressed with a cotton pellet that is made damp with Allium Sativum oil for 1 min .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mineral Trioxide Aggregate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The material will be prepared according to the manufacturer's instructions , applied to the pulp chamber and a moistened cotton pellet was placed over the MTA paste to allow the material to set.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Allium Sativum Oil</intervention_name>
    <description>Garlic oil Captain Company (CAP-PHARM)</description>
    <arm_group_label>Allium sativum oil</arm_group_label>
    <other_name>Garlic oil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mineral Tri-Oxide Aggregate</intervention_name>
    <description>ProRoot MTA, Dentsply</description>
    <arm_group_label>Mineral Trioxide Aggregate</arm_group_label>
    <other_name>MTA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Apparently healthy children aged from 5- 7 years.&#xD;
&#xD;
          -  Children not having antibiotics in the past 14 days.&#xD;
&#xD;
          -  Cooperative children.&#xD;
&#xD;
          -  Children are having at least two carious asymptomatic second primary molars.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Uncooperative children.&#xD;
&#xD;
          -  Immunocompromised children.&#xD;
&#xD;
          -  Children with clinical or radiographic symptoms&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 20, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 27, 2021</study_first_posted>
  <last_update_submitted>August 19, 2021</last_update_submitted>
  <last_update_submitted_qc>August 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Lobna Magdy</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <keyword>Allium sativum oil</keyword>
  <keyword>MTA</keyword>
  <keyword>pulpotomy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Allyl sulfide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

